This startup develops a wearable medical device for fecal incontinence prevention. The device combines mechanical support with electrical stimulation to provide a discrete, non-invasive therapy, helping patients manage their condition and improve quality of life.
Funding
Funding not disclosed
Founders
Product
Problem
Fecal incontinence affects a significant portion of middle-aged adults, leading to a diminished quality of life. Current solutions often lack discretion, are invasive, or do not provide continuous therapy.
Solution
BeCapio is developing a non-invasive system that combines mechanical support with on-demand and continuous electrical stimulation to address fecal incontinence. The system consists of a small, reusable control unit and a discrete, disposable anal patch. The control unit generates electrical pulses to stimulate anal sphincters and pelvic muscles, while the anal patch provides external sealing and delivers targeted stimulation via skin electrodes. The system is designed to provide immediate leak prevention, on-demand muscle reinforcement, and overtime improvement through continuous therapy and biofeedback.
Target Audience
The primary target audience includes middle-aged adults suffering from frequent fecal incontinence seeking a non-invasive and discrete solution to manage their condition.
Features
- Reusable control unit with an intuitive user interface for prompt activation.
- Bluetooth connectivity for healthcare provider configuration of stimulation intensity and duration.
- Electromyography (EMG) and impedance signal measurement for quantifying squeezing improvement and training feedback.
- Disposable anal patch with an ergonomic design for optimal application and secure skin attachment.
- Soft silicone plug with a rigid skeleton to provide external sealing.
- Skin electrodes positioned for accurate stimulation of the anal sphincters.